Difference between revisions of "Moclobemide-tranylcypromine"

From Psychiatrienet
Jump to: navigation, search
Line 5: Line 5:
 
{{stopMoclobemide}}
 
{{stopMoclobemide}}
 
| start =   
 
| start =   
* '''Day 9:''' a wash-out period of two days is necessary.
+
* '''Day 9:''' start tranylcypromine in a low dosage of 20 mg/day for one week.
* '''Day 10:''' start tranylcypromine after this period in a low dosage of 20 mg/day for one week.
+
* '''Day 16:''' after this week the dosage of tranylcypromine can be increased if necessary.
* '''Day 17:''' after this week the dosage of tranylcypromine can be increased if necessary.
+
 
 
|info=
 
|info=
{{review}}
+
{{shortt1/2}}
 
}}
 
}}

Revision as of 14:17, 14 October 2015

Moclobemide
Type Antidepressant
Group MAO-I
links
Medscape Moclobemide
PubChem 4235
PubMed Moclobemide
Kompas (Dutch) Moclobemide
Wikipedia Moclobemide
Tranylcypromine
Type Antidepressant
Group MAO-I
links
Medscape Tranylcypromine
PubChem 5530
PubMed Tranylcypromine
Wikipedia Tranylcypromine

Switch medication from moclobemide to tranylcypromine.

Nietinrijdenbord.png Stop moclobemide
  • Before day 1: gradually reduce dosage of moclobemide to a maximum of 300 mg/day.
  • Day 1: reduce the dosage of moclobemide to 150 mg/day.
  • Day 8: stop administration of moclobemide.
Eenrichtingbord.png Start tranylcypromine
  • Day 9: start tranylcypromine in a low dosage of 20 mg/day for one week.
  • Day 16: after this week the dosage of tranylcypromine can be increased if necessary.
Infobord.png More information
  • Because of short halve life of moclobemide after stopping, the next antidepressant can start next day.
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.